HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiya Tanaka Selected Research

Prednisolone (Predate)

4/2024Two Cases of Painful Thyroiditis With Subsequent Hypothyroidism Following Cord Blood Transplant.
10/2023Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
10/2022Clinical features of Behçet's disease patients with joint symptoms in Japan: A national multicenter study.
1/2021A case of systemic lupus erythematosus with marked ascites due to idiopathic non-cirrhotic portal hypertension.
1/2020A case of systemic lupus erythematosus in which Cushing's syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids.
9/2017A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease.
11/2016Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study.
6/2015Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis.
9/2014A case of teriparatide-induced severe hypophosphatemia and hypercalcemia.
1/2014Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiya Tanaka Research Topics

Disease

328Rheumatoid Arthritis
04/2024 - 07/2001
86Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2024 - 10/2003
50Type 2 Diabetes Mellitus (MODY)
04/2024 - 06/2005
45Infections
04/2024 - 02/2004
37Autoimmune Diseases (Autoimmune Disease)
03/2024 - 02/2002
36Neoplasms (Cancer)
04/2024 - 01/2002
35Osteoporosis
03/2024 - 06/2003
34Inflammation (Inflammations)
04/2024 - 07/2001
26Herpes Zoster
04/2024 - 01/2016
23Psoriatic Arthritis
04/2024 - 07/2016
21Hypoglycemia (Reactive Hypoglycemia)
12/2023 - 02/2006
19Immunoglobulin G4-Related Disease
12/2023 - 02/2012
15Arthritis (Polyarthritis)
03/2024 - 02/2004
15Necrosis
02/2024 - 08/2012
15Pathologic Processes
01/2022 - 03/2002
14Psoriasis (Pustulosis Palmaris et Plantaris)
03/2024 - 01/2004
14Hyperglycemia
12/2023 - 06/2005
14Bone Resorption
10/2023 - 08/2002
13Pain (Aches)
10/2023 - 03/2013
12Rheumatic Diseases (Rheumatism)
09/2020 - 01/2007
11Systemic Scleroderma (Systemic Sclerosis)
04/2024 - 07/2015
10Lupus Nephritis
11/2023 - 01/2016
9Interstitial Lung Diseases (Interstitial Lung Disease)
07/2023 - 06/2002
9Bone Fractures (Bone Fracture)
11/2019 - 06/2003
8Drug-Related Side Effects and Adverse Reactions
12/2023 - 10/2011
8Body Weight (Weight, Body)
11/2023 - 10/2008
8Fibrosis (Cirrhosis)
03/2023 - 10/2009
8Hypercalcemia (Milk Alkali Syndrome)
10/2020 - 01/2004
7Fatigue
01/2024 - 11/2017
7Graves Disease (Basedow Disease)
05/2023 - 01/2014
7Dermatomyositis (Dermatopolymyositis)
11/2022 - 01/2008
7Vascular Calcification
01/2019 - 08/2006
7Diabetes Mellitus
01/2017 - 06/2006
7Atherosclerosis
05/2016 - 05/2003
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 01/2015
6Mixed Connective Tissue Disease (MCTD)
04/2024 - 01/2005
6Disease Progression
09/2023 - 07/2004
6Atopic Dermatitis (Atopic Eczema)
08/2023 - 07/2013
6Pulmonary Arterial Hypertension
07/2023 - 01/2020

Drug/Important Bio-Agent (IBA)

87Methotrexate (Mexate)FDA LinkGeneric
03/2024 - 12/2002
54Antirheumatic Agents (DMARD)IBA
04/2024 - 02/2004
53GlucocorticoidsIBA
03/2024 - 06/2003
50Janus Kinase InhibitorsIBA
04/2024 - 01/2012
43Glucose (Dextrose)FDA LinkGeneric
12/2023 - 01/2006
36CytokinesIBA
01/2024 - 07/2001
35Adalimumab (Humira)FDA Link
04/2024 - 06/2012
32baricitinibIBA
07/2023 - 03/2016
31tofacitinibIBA
12/2023 - 08/2011
31Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2023 - 06/2005
28tocilizumab (atlizumab)FDA Link
11/2023 - 04/2011
25Monoclonal AntibodiesIBA
01/2023 - 01/2008
23Tumor Necrosis Factor InhibitorsIBA
04/2024 - 07/2011
22Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2005
21Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2009
21Abatacept (Orencia)FDA Link
11/2023 - 01/2014
21Janus KinasesIBA
10/2023 - 01/2014
19Etanercept (Enbrel)FDA Link
01/2023 - 01/2009
19Interleukin-6 (Interleukin 6)IBA
01/2023 - 11/2007
19Diphosphonates (Bisphosphonates)IBA
05/2021 - 11/2002
18Immunoglobulin G (IgG)IBA
03/2023 - 02/2012
17AutoantibodiesIBA
12/2021 - 12/2002
16peficitinibIBA
12/2023 - 06/2016
16Infliximab (Remicade)FDA Link
11/2021 - 01/2007
15GLPG0634IBA
12/2023 - 01/2021
14upadacitinibIBA
04/2024 - 01/2019
14Prednisolone (Predate)FDA LinkGeneric
04/2024 - 02/2004
14Rituximab (Mabthera)FDA Link
09/2023 - 01/2007
14Insulin (Novolin)FDA Link
11/2022 - 06/2005
14Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2013
13AntibodiesIBA
04/2024 - 06/2011
13DenosumabFDA Link
12/2023 - 05/2010
13Certolizumab PegolFDA Link
07/2023 - 07/2014
12Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2023 - 10/2003
11DNA (Deoxyribonucleic Acid)IBA
05/2023 - 10/2003
11Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2018 - 12/2004
10SteroidsIBA
03/2024 - 10/2003
10belimumabIBA
11/2023 - 01/2018
10anifrolumabIBA
11/2023 - 01/2020
10sarilumabIBA
08/2023 - 09/2014
9Interleukin-17 (Interleukin 17)IBA
03/2024 - 03/2011
9C-Reactive ProteinIBA
12/2023 - 12/2006
9Proteins (Proteins, Gene)FDA Link
10/2023 - 06/2005
9InterferonsIBA
08/2023 - 06/2012
9Hemoglobins (Hemoglobin)IBA
04/2022 - 03/2005
8Vitamin DFDA LinkGeneric
04/2024 - 12/2012
8InterleukinsIBA
03/2024 - 12/2014
7Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
09/2023 - 01/2020
7Phosphotransferases (Kinase)IBA
08/2023 - 11/2012
7Immunosuppressive Agents (Immunosuppressants)IBA
07/2023 - 10/2006
7Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 12/2012
7AntigensIBA
01/2021 - 08/2002
7Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
12/2020 - 04/2013
6bimekizumabIBA
02/2024 - 01/2023
6LipidsIBA
02/2023 - 10/2008
6quetmolimabIBA
01/2023 - 01/2018

Therapy/Procedure

166Therapeutics
03/2024 - 09/2002
10Remission Induction
01/2023 - 02/2004
9Glycemic Control
02/2023 - 06/2006
8Precision Medicine
04/2023 - 07/2016
6Drug Therapy (Chemotherapy)
03/2023 - 07/2004